Evaluation of Pre-Pandemic Trivalent COBRA HA Vaccine in Mice Pre-Immune to Historical H1N1 and H3N2 Influenza Viruses
Viruses · 2023
DOI: 10.3390/v15010203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Pan Ge und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602, USA. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines, Influenza A Virus, H1N1 Subtype, Orthomyxoviridae Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, a component of the NIH, Department of Health and Human Services.
Abstract (Originalsprache)
Initial exposure to influenza virus(es) during early childhood produces protective antibodies that may be recalled following future exposure to subsequent viral infections or vaccinations. Most influenza vaccine research studies use immunologically naïve animal models to assess vaccine effectiveness. However, most people have an extensive influenza immune history, with memory cells produced by viruses or vaccines representing multiple influenza viruses. In this study, we explored the effect influenza seasonal virus-induced immunity has on pre-pandemic influenza virus vaccination. The mice that were pre-immune to historical H1N1 and H3N2 seasonal influenza viruses were vaccinated with adjuvanted pre-pandemic (H2, H5, and H7) HA-based computationally optimized broadly reactive antigen (COBRA) vaccines, and were fully protected from lethal challenge, whereas the mock-vaccinated mice, with or without pre-immunity, were not protected from morbidity or mortality. Detectable antibody titers were present in the pre-immune mice vaccinated with a single dose of vaccine, but not in the immunologically naïve mice. The mice vaccinated twice with the trivalent COBRA HA vaccine had similar antibody titers regardless of their pre-immune status. Overall, seasonal pre-immunity did not interfere with the immune responses elicited by pre-pandemic COBRA HA vaccines or the protection against pre-pandemic viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602, USA.
- Florida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL 34987, USA.
- Department of Infectious Diseases, University of Georgia, Athens, GA 30602, USA.
- Department of Infection Biology, Lehner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases, a component of the NIH, Department of Health and Human Services
Zitieren
APA
Ge, P., & Ross, T. M. (2023). Evaluation of Pre-Pandemic Trivalent COBRA HA Vaccine in Mice Pre-Immune to Historical H1N1 and H3N2 Influenza Viruses. Viruses. https://doi.org/10.3390/v15010203
Vancouver
Ge P, Ross TM. Evaluation of Pre-Pandemic Trivalent COBRA HA Vaccine in Mice Pre-Immune to Historical H1N1 and H3N2 Influenza Viruses. Viruses. 2023. doi:10.3390/v15010203
BibTeX
@article{Ge2023,
author = {Ge, Pan and Ross, Ted M},
title = {Evaluation of Pre-Pandemic Trivalent COBRA HA Vaccine in Mice Pre-Immune to Historical H1N1 and H3N2 Influenza Viruses},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15010203}
}
EUVIMED